Drug patent protection: it’s time for a ‘one-and-done’ approach – STAT

Drug patent protection: it’s time for a ‘one-and-done’ approach  STAT

That approach to drug patents that gives companies a single period of exclusivity could prevent the patent thickets that stifle generic competition.